Electrocorticographic events from long-term ambulatory brain recordings can potentially supplement seizure diaries
Electrocorticographic events from long-term ambulatory brain recordings can potentially supplement seizure diaries
复制标题
DOI:
10.1016/j.eplepsyres.2020.106302
复制
发表时间:
2020-03-01
影响因子:
2.2
通讯作者:
Morrell, Martha J.
中科院分区:
文献类型:
--
作者:
Quigg, Mark;Skarpaas, Tara L.;Morrell, Martha J.
Purpose: To determine the feasibility of using epileptiform events detected by continuous electrocorticographic monitoring via a brain-responsive neurostimulation system to supplement patient-maintained seizure diaries.Methods: Data were retrospectively analyzed from a randomized controlled trial of brain-responsive neurostimulation (RNS (R) System) for adjunctive treatment of medically intractable focal onset seizures in 191 subjects. The long-term (>= 3 months) correspondence between daily counts of diary-reported seizures and device-recorded "long epileptiform events" (LEs), a proxy for electrographic seizures (ESs), was assessed using cross-correlation and logistic generalized estimating equation models.Results: Diary-reported seizures and LEs significantly co-varied across days in 124 patients whose detection settings were held constant, with a significantly higher correlation in 54 patients (44 %) whose LEs were usually ESs (high concordance patients). There were more days in which LEs were detected than days in which patients reported a seizure (positive predictive value (PPV): 34 %). On days when there were no LEs, there were typically no diary-reported seizures (negative predictive value (NPV): 90 %). In patients with a high concordance between LEs and ESs, the PPV and NPV were both slightly higher, 43 % (35-52 %) and 93 % (95 % CI: 86-97 %) respectively.Conclusion: Although LEs can substantially outnumber diary reported seizures, the high across-day correlation and strong NPV between LEs and diary seizures suggests that LEs recorded by the RNS (R) System could potentially supplement seizure diaries by providing an objective biomarker for relative seizure burden.